ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,392 | -15.4% | 12,183 | +19.0% | 0.00% | 0.0% |
| Q2 2023 | $288,786 | +33.3% | 10,237 | -4.9% | 0.00% | 0.0% |
| Q4 2022 | $216,686 | -0.1% | 10,759 | +7.9% | 0.00% | 0.0% |
| Q3 2022 | $217,000 | -11.4% | 9,968 | +14.1% | 0.00% | 0.0% |
| Q2 2022 | $245,000 | -54.1% | 8,738 | -24.4% | 0.00% | 0.0% |
| Q1 2022 | $534,000 | -55.7% | 11,556 | -19.5% | 0.00% | -50.0% |
| Q4 2021 | $1,206,000 | +27.3% | 14,350 | +0.9% | 0.00% | -33.3% |
| Q3 2021 | $947,000 | +10.9% | 14,218 | -11.4% | 0.00% | +50.0% |
| Q2 2021 | $854,000 | +48.0% | 16,048 | +20.6% | 0.00% | 0.0% |
| Q1 2021 | $577,000 | -12.0% | 13,303 | +5.3% | 0.00% | 0.0% |
| Q4 2020 | $656,000 | – | 12,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |